BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fujii H, Itoh Y, Yamaguchi K, Yamauchi N, Harano Y, Nakajima T, Minami M, Okanoue T. Chemokine CCL20 enhances the growth of HuH7 cells via phosphorylation of p44/42 MAPK in vitro. Biochem Biophys Res Commun. 2004;322:1052-1058. [PMID: 15336571 DOI: 10.1016/j.bbrc.2004.07.207] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Zeng W, Chang H, Ma M, Li Y. CCL20/CCR6 promotes the invasion and migration of thyroid cancer cells via NF-kappa B signaling-induced MMP-3 production. Exp Mol Pathol. 2014;97:184-190. [PMID: 24984269 DOI: 10.1016/j.yexmp.2014.06.012] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 4.7] [Reference Citation Analysis]
2 Ding X, Wang K, Wang H, Zhang G, Liu Y, Yang Q, Chen W, Hu S. High expression of CCL20 is associated with poor prognosis in patients with hepatocellular carcinoma after curative resection. J Gastrointest Surg. 2012;16:828-836. [PMID: 22072303 DOI: 10.1007/s11605-011-1775-4] [Cited by in Crossref: 21] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
3 Chen W, Zhang J, Fan HN, Zhu JS. Function and therapeutic advances of chemokine and its receptor in nonalcoholic fatty liver disease. Therap Adv Gastroenterol 2018;11:1756284818815184. [PMID: 30574191 DOI: 10.1177/1756284818815184] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 4.7] [Reference Citation Analysis]
4 Yapa S, Mulla O, Green V, England J, Greenman J. The Role of Chemokines in Thyroid Carcinoma. Thyroid 2017;27:1347-59. [PMID: 28891394 DOI: 10.1089/thy.2016.0660] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
5 Zhang X, Meng A, Wang H, Yan X. High serum macrophage inflammatory protein-3α is associated with the early recurrence or metastasis of non-small cell lung cancer following primary pulmonary resection. Oncol Lett 2014;8:948-52. [PMID: 25013520 DOI: 10.3892/ol.2014.2229] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
6 Baumforth KR, Birgersdotter A, Reynolds GM, Wei W, Kapatai G, Flavell JR, Kalk E, Piper K, Lee S, Machado L. Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin’s lymphoma cells mediates Up-regulation of CCL20 and the migration of regulatory T cells. Am J Pathol. 2008;173:195-204. [PMID: 18502823 DOI: 10.2353/ajpath.2008.070845] [Cited by in Crossref: 114] [Cited by in F6Publishing: 108] [Article Influence: 8.8] [Reference Citation Analysis]
7 Ghasemi R, Ghaffari SH, Momeny M, Pirouzpanah S, Yousefi M, Malehmir M, Alimoghaddam K, Ghavamzadeh A. Multitargeting and antimetastatic potentials of silibinin in human HepG-2 and PLC/PRF/5 hepatoma cells. Nutr Cancer. 2013;65:590-599. [PMID: 23659451 DOI: 10.1080/01635581.2013.770043] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 2.3] [Reference Citation Analysis]
8 Singh SK, Mishra MK, Rivers BM, Gordetsky JB, Bae S, Singh R. Biological and Clinical Significance of the CCR5/CCL5 Axis in Hepatocellular Carcinoma. Cancers (Basel). 2020;12. [PMID: 32260550 DOI: 10.3390/cancers12040883] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 8.0] [Reference Citation Analysis]
9 Tsai S, Chien I, Shen W, Kuo Y, Jin Y, Wong T, Hsiao J, Wang H, Shih N, Wu L. ENO1, a potential prognostic head and neck cancer marker, promotes transformation partly via chemokine CCL20 induction. European Journal of Cancer 2010;46:1712-23. [DOI: 10.1016/j.ejca.2010.03.018] [Cited by in Crossref: 68] [Cited by in F6Publishing: 65] [Article Influence: 6.2] [Reference Citation Analysis]
10 Lei KF, Chang CH, Chen MJ. Paper/PMMA Hybrid 3D Cell Culture Microfluidic Platform for the Study of Cellular Crosstalk. ACS Appl Mater Interfaces 2017;9:13092-101. [PMID: 28353331 DOI: 10.1021/acsami.7b03021] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 5.5] [Reference Citation Analysis]
11 Zhuang L, Wu Y, Han J, Ling X, Wang L, Zhu C, Fu Y. A network biology approach to discover the molecular biomarker associated with hepatocellular carcinoma. Biomed Res Int 2014;2014:278956. [PMID: 24949431 DOI: 10.1155/2014/278956] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
12 Pan X, Kaminga AC, Wen SW, Liu A. Chemokines in hepatocellular carcinoma: a meta-analysis. Carcinogenesis 2020;41:1682-94. [PMID: 33300549 DOI: 10.1093/carcin/bgaa106] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Du D, Liu Y, Qian H, Zhang B, Tang X, Zhang T, Liu W. The effects of the CCR6/CCL20 biological axis on the invasion and metastasis of hepatocellular carcinoma. Int J Mol Sci. 2014;15:6441-6452. [PMID: 24743888 DOI: 10.3390/ijms15046441] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
14 Hou KZ, Fu ZQ, Gong H. Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition. World J Gastroenterol 2015; 21(2): 475-483 [PMID: 25593462 DOI: 10.3748/wjg.v21.i2.475] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
15 Liang CM, Chen L, Hu H, Ma HY, Gao LL, Qin J, Zhong CP. Chemokines and their receptors play important roles in the development of hepatocellular carcinoma. World J Hepatol 2015; 7(10): 1390-1402 [PMID: 26052384 DOI: 10.4254/wjh.v7.i10.1390] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 4.7] [Reference Citation Analysis]
16 Ikeda S, Kitadate A, Ito M, Abe F, Nara M, Watanabe A, Takahashi N, Miyagaki T, Sugaya M, Tagawa H. Disruption of CCL20-CCR6 interaction inhibits metastasis of advanced cutaneous T-cell lymphoma. Oncotarget 2016;7:13563-74. [PMID: 26789110 DOI: 10.18632/oncotarget.6916] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
17 Chaudhry S, Emond J, Griesemer A. Immune Cell Trafficking to the Liver. Transplantation 2019;103:1323-37. [PMID: 30817405 DOI: 10.1097/TP.0000000000002690] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 9.0] [Reference Citation Analysis]
18 Soliman HH, Nagy H, Kotb N, Alm El-Din MA. The role of chemokine CC ligand 20 in patients with liver cirrhosis and hepatocellular carcinoma. Int J Biol Markers. 2012;27:e125-e131. [PMID: 22388957 DOI: 10.5301/jbm.2012.9097] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
19 Huang Y, Peng Q, Li HY, Jia ZD, Li Y, Gao Y. Novel sericin-based hepatocyte serum-free medium and sericin’s effect on hepatocyte transcriptome. World J Gastroenterol 2018; 24(30): 3398-3413 [PMID: 30122879 DOI: 10.3748/wjg.v24.i30.3398] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
20 Li C, Kang D, Sun X, Liu Y, Wang J, Gao P. The Effect of C-X-C Motif Chemokine 13 on Hepatocellular Carcinoma Associates with Wnt Signaling. Biomed Res Int 2015;2015:345413. [PMID: 26161394 DOI: 10.1155/2015/345413] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
21 Korbecki J, Grochans S, Gutowska I, Barczak K, Baranowska-Bosiacka I. CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands. Int J Mol Sci. 2020;21. [PMID: 33076281 DOI: 10.3390/ijms21207619] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 15.0] [Reference Citation Analysis]
22 Solinas A, Calvisi DF. Lessons from rare tumors: Hepatic lymphoepithelioma-like carcinomas. World J Gastroenterol 2015; 21(12): 3472-3479 [PMID: 25834311 DOI: 10.3748/wjg.v21.i12.3472] [Cited by in CrossRef: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
23 Marra F, Tacke F. Roles for chemokines in liver disease. Gastroenterology 2014; 147: 577-594. e1. [PMID: 25066692 DOI: 10.1053/j.gastro.2014.06.043] [Cited by in Crossref: 406] [Cited by in F6Publishing: 405] [Article Influence: 58.0] [Reference Citation Analysis]
24 Ghadjar P, Loddenkemper C, Coupland SE, Stroux A, Noutsias M, Thiel E, Christoph F, Miller K, Scheibenbogen C, Keilholz U. Chemokine receptor CCR6 expression level and aggressiveness of prostate cancer. J Cancer Res Clin Oncol 2008;134:1181-9. [DOI: 10.1007/s00432-008-0403-5] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 2.5] [Reference Citation Analysis]
25 Huang F, Geng XP. Chemokines and hepatocellular carcinoma. World J Gastroenterol 2010; 16(15): 1832-1836 [PMID: 20397259 DOI: 10.3748/wjg.v16.i15.1832] [Cited by in CrossRef: 44] [Cited by in F6Publishing: 46] [Article Influence: 4.0] [Reference Citation Analysis]
26 Ehling J, Tacke F. Role of chemokine pathways in hepatobiliary cancer. Cancer Lett. 2015; Jun 26. [Epub ahead of print]. [PMID: 26123664 DOI: 10.1016/j.canlet.2015.06.017] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 6.3] [Reference Citation Analysis]
27 Lee S, Lee J, Min S, Won D, Lee Y, Lim H, Lee W, Pae H, Chung H, Jun C, Lee S, Kim E. Iron chelator differentially activates macrophage inflammatory protein-3α/CCL20 in immortalized and malignant human oral keratinocytes. Archives of Oral Biology 2008;53:801-9. [DOI: 10.1016/j.archoralbio.2008.01.015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
28 Nguyen H, Sankaran S, Dandekar S. Hepatitis C virus core protein induces expression of genes regulating immune evasion and anti-apoptosis in hepatocytes. Virology. 2006;354:58-68. [PMID: 16876223 DOI: 10.1016/j.virol.2006.04.028] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 3.1] [Reference Citation Analysis]
29 Costantini S, Di Bernardo G, Cammarota M, Castello G, Colonna G. Gene expression signature of human HepG2 cell line. Gene 2013;518:335-45. [DOI: 10.1016/j.gene.2012.12.106] [Cited by in Crossref: 61] [Cited by in F6Publishing: 61] [Article Influence: 7.6] [Reference Citation Analysis]
30 Heo YJ, Choi SE, Lee N, Jeon JY, Han SJ, Kim DJ, Kang Y, Lee KW, Kim HJ. CCL20 induced by visfatin in macrophages via the NF-κB and MKK3/6-p38 signaling pathways contributes to hepatic stellate cell activation. Mol Biol Rep 2020;47:4285-93. [PMID: 32418112 DOI: 10.1007/s11033-020-05510-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
31 Brand S, Olszak T, Beigel F, Diebold J, Otte JM, Eichhorst ST, Göke B, Dambacher J. Cell differentiation dependent expressed CCR6 mediates ERK-1/2, SAPK/JNK, and Akt signaling resulting in proliferation and migration of colorectal cancer cells. J Cell Biochem 2006;97:709-23. [PMID: 16215992 DOI: 10.1002/jcb.20672] [Cited by in Crossref: 100] [Cited by in F6Publishing: 100] [Article Influence: 6.7] [Reference Citation Analysis]